Swedish instrument company Inhalation Sciences has announced the appointment of Lena Heffler as its new CEO effective May 7, 2018. She will succeed Fredrik Sjövall, who is expected to become Chairman of the Board. Heffler said, "Inhalation Sciences is a company with a unique and very exciting technology platform that has the potential to make a huge difference to … [Read more...] about Inhalation Sciences names Lena Heffler as CEO
People
Pneuma Respiratory appoints Steven Kesten as President and Chief Medical Officer
Pneuma Respiratory, which introduced a digital soft mist inhaler in November 2017, has announced the appointment of former Boehringer Ingelheim VP of Respiratory Products Steven Kesten as its new President and Chief Medical Officer. Since leaving Boehringer Ingelheim in 2010, Kesten has held VP and Chief Medical Officer positions at Uptake Medical and Cytori … [Read more...] about Pneuma Respiratory appoints Steven Kesten as President and Chief Medical Officer
Copley Scientific appoints Richard Postlethwaite as Chief Operating Officer
Copley Scientific has announced the appointment of an experienced lean manufacturing consultant, Richard Postlethwaite, as Chief Operating Officer. Postlethwaite was most recently Senior Operations Manager of Walgreens Boots Alliance and previously held a number of positions at Reckitt Benckiser and Boots. The company, which recently completed an expansion of its … [Read more...] about Copley Scientific appoints Richard Postlethwaite as Chief Operating Officer
Benjamin Wolin joins the board of Dance Biopharm
Inhaled insulin developer Dance Biopharm has announced that Diplomat Specialty Pharmacy Chairman Benjamin Wolin has joined its board of directors. In 2002, Wolin co-founded digital marketing company Everyday Health and led the company until its acquisition by Ziff Davis in 2016. In December 2017, Dance announced that it had partnered with Phillips-Medisize for … [Read more...] about Benjamin Wolin joins the board of Dance Biopharm
MannKind initiates Phase 1 trial of Treprostinil Technosphere DPI for PAH
MannKind Corporation has announced the initiation of a Phase 1 clinical study of its dry powder formulation of treprostinil based on its Technosphere inhaled delivery technology for the treatment of pulmonary arterial hypertension (PAH). The company said that the Treprostinil Technosphere (TreT) study is being conducted under an IND filed with the FDA in January. … [Read more...] about MannKind initiates Phase 1 trial of Treprostinil Technosphere DPI for PAH
Kevin Gordon named President and CFO of Liquidia Technologies
Liquidia Technologies, which recently published positive Phase 1 results for its LIQ861 treprostinil DPI for the treatment of pulmonary arterial hypertension, has named former Quintiles executive Kevin Gordon as President and Chief Financial Officer. Gordon was most recently Executive VP and Chief Operating Officer of Quintiles. He held various business development … [Read more...] about Kevin Gordon named President and CFO of Liquidia Technologies
Proveris Scientific announces appointment of Chip Leveille as President
OINDP testing specialist Proveris Scientific Corporation has announced the appointment of Chip Leveille as President, effective immediately. Leveille had been the Chief Commercial Officer at the company since April 2016 and previously held positions at BioScale, Helicos, Affymetrix, and Zymark Corporation. Leveille commented, "I am very excited to lead Proveris in … [Read more...] about Proveris Scientific announces appointment of Chip Leveille as President
Roger Jeffs joins board of Spyryx Biosciences
Spyryx Biosciences, which recently initiated a Phase 2 study of its SPX-101 inhaled SPLUNC1-derived peptide for the treatment of cystic fibrosis, announced that former United Therapeutics CEO Roger Jeffs has joined its board of directors. Jeffs served as President and COO of United Therapeutics from 1998-2014 and as President and CEO from January 2015 until mid … [Read more...] about Roger Jeffs joins board of Spyryx Biosciences
Savara appoints Peter Ginsberg as VP of Business Development
Inhaled drug developer Savara has announced the appointment of Peter Ginsberg as VP of Business Development. Ginsberg was most recently VP of Business Development at BioDelivery Sciences International and had previously held business development positions at a number of companies, including United Therapeutics and Surmodics. He also has experience as a biotechnology … [Read more...] about Savara appoints Peter Ginsberg as VP of Business Development
Neurodyn Cognition names Anthony Giovinazzo as Executive Chairman
Neurodyn Cognition (NCI), a Canadian company developing an intranasal therapy for Alzheimer's disease, has named Anthony Giovinazzo as a director and Executive Chairman. Giovinazzo was most recently President and CEO of Cynapsus Therapeutics, which was sold to Sunovion in 2016. NCI's Memogain is described as an intranasal formulation of a prodrug of galantamine, … [Read more...] about Neurodyn Cognition names Anthony Giovinazzo as Executive Chairman